Dual specificity protein kinase
From Proteopedia
(Difference between revisions)
Line 13: | Line 13: | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
- | *CLK1 | + | *CLK1 kinase domain |
- | **[[1z57]] – hCLK1 | + | **[[1z57]] – hCLK1 + himenialdizine – human |
- | **[[2vag]] | + | **[[5j1v]], [[5j1w]], [[2vag]], [[5x8i]] – hCLK1 + inhibitor<br /> |
- | **[[ | + | **[[6g33]] – hCLK1 + iodotubercidine inhibitor<br /> |
- | *CLK2 | + | *CLK2 kinase domain |
- | **[[3nr9]] – hCLK2 | + | **[[3nr9]] – hCLK2<br /> |
+ | **[[5unp]] – hCLK2 + inhibitor<br /> | ||
*CLK3 | *CLK3 | ||
Line 36: | Line 37: | ||
*TTK | *TTK | ||
- | **[[3cek]], [[3dbq]] – hTTK kinase domain<br /> | + | **[[3cek]], [[3dbq]], [[2zmc]] – hTTK kinase domain<br /> |
**[[4b94]], [[4h7x]], [[4h7y]] - hTTK TPR domain<br /> | **[[4b94]], [[4h7x]], [[4h7y]] - hTTK TPR domain<br /> | ||
**[[3gfw]] - hTTK kinase domain + pyrolo-pyridin ligand | **[[3gfw]] - hTTK kinase domain + pyrolo-pyridin ligand | ||
Line 42: | Line 43: | ||
**[[3h9f]] - hTTK kinase domain + pyrimidino-diazepin ligand | **[[3h9f]] - hTTK kinase domain + pyrimidino-diazepin ligand | ||
- | **[[2x9e]], [[3vqu]], [[3w1f]], [[4bhz]], [[4bi0]], [[4bi1]], [[4bi2]], [[4c4e]], [[4c4f]], [[4c4g]], [[4c4h]], [[4c4i]], [[4c4j]], [[4js8]], [[4jt3]], [[3wzj]], [[3wzk]], [[4o6l]], [[5ehl]], [[5eho]], [[5ehy]], [[5ei2]], [[5ei6]], [[5ei8]], [[5ap0]], [[5ap1]], [[5ap2]], [[5eh0]], [[4zeg]] - hTTK kinase domain + inhibitor | + | **[[2x9e]], [[3vqu]], [[3w1f]], [[4bhz]], [[4bi0]], [[4bi1]], [[4bi2]], [[4c4e]], [[4c4f]], [[4c4g]], [[4c4h]], [[4c4i]], [[4c4j]], [[4js8]], [[4jt3]], [[3wzj]], [[3wzk]], [[4o6l]], [[5ehl]], [[5eho]], [[5ehy]], [[5ei2]], [[5ei6]], [[5ei8]], [[5ap0]], [[5ap1]], [[5ap2]], [[5eh0]], [[4zeg]], [[6b4w]], [[5na0]], [[5n9s]], [[5n93]], [[5n87]], [[5n84]], [[5n7v]] - hTTK kinase domain + inhibitor |
- | + | **[[2zmd]], [[5ap3]], [[5ap4]], [[5ap5]], [[5ap6]], [[5ap7]], [[5o91]], [[5ntt]], [[5nad]], [[5mrb]] - hTTK kinase domain (mutant) + inhibitor<br /> | |
- | + | ||
- | **[[2zmd]], [[5ap3]], [[5ap4]], [[5ap5]], [[5ap6]], [[5ap7]] - hTTK kinase domain (mutant) + inhibitor<br /> | + | |
**[[3hmn]] - hTTK kinase domain + ATP | **[[3hmn]] - hTTK kinase domain + ATP |
Revision as of 09:27, 9 May 2018
|
3D structures of dual specificity protein kinase
Updated on 09-May-2018
References
- ↑ Dhanasekaran N, Premkumar Reddy E. Signaling by dual specificity kinases. Oncogene. 1998 Sep 17;17(11 Reviews):1447-55. PMID:9779990 doi:http://dx.doi.org/10.1038/sj.onc.1202251
- ↑ Colombo R, Caldarelli M, Mennecozzi M, Giorgini ML, Sola F, Cappella P, Perrera C, Depaolini SR, Rusconi L, Cucchi U, Avanzi N, Bertrand JA, Bossi RT, Pesenti E, Galvani A, Isacchi A, Colotta F, Donati D, Moll J. Targeting the Mitotic Checkpoint for Cancer Therapy with NMS-P715, an Inhibitor of MPS1 Kinase. Cancer Res. 2010 Dec 15;70(24):10255-64. PMID:21159646 doi:10.1158/0008-5472.CAN-10-2101